Invivyd Net Income
| IVVD Stock | USD 1.56 0.03 1.96% |
As of the 15th of February 2026, Invivyd retains the Downside Deviation of 5.55, market risk adjusted performance of (0.46), and Risk Adjusted Performance of 0.0313. Invivyd technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Please check out Invivyd information ratio, potential upside, as well as the relationship between the Potential Upside and kurtosis to decide if Invivyd is priced fairly, providing market reflects its last-minute price of 1.56 per share. Please also validate Invivyd total risk alpha, which is currently at (0.36) to confirm the company can sustain itself at a future point.
Invivyd Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization | Enterprise Value Revenue 7.1748 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Loss | -217.2 M | -228 M | |
| Net Loss | -152.9 M | -160.6 M | |
| Net Loss | -195.4 M | -205.2 M | |
| Net Loss | (1.65) | (1.73) |
Invivyd | Net Income | Build AI portfolio with Invivyd Stock |
Analyzing Invivyd's Net Income over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Net Income has evolved provides context for assessing Invivyd's current valuation and future prospects.
Latest Invivyd's Net Income Growth Pattern
Below is the plot of the Net Income of Invivyd over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Invivyd financial statement analysis. It represents the amount of money remaining after all of Invivyd operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Invivyd's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Invivyd's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (169.93 M) | 10 Years Trend |
|
Net Income |
| Timeline |
Invivyd Net Income Regression Statistics
| Arithmetic Mean | (140,112,738) | |
| Coefficient Of Variation | (31.60) | |
| Mean Deviation | 36,412,965 | |
| Median | (111,975,447) | |
| Standard Deviation | 44,273,165 | |
| Sample Variance | 1960.1T | |
| Range | 129.3M | |
| R-Value | (0.65) | |
| Mean Square Error | 1212.5T | |
| R-Squared | 0.42 | |
| Significance | 0 | |
| Slope | (5,682,289) | |
| Total Sum of Squares | 31361.8T |
Invivyd Net Income History
Other Fundumenentals of Invivyd
| Net Income Applicable To Common Shares | ||
| Net Income From Continuing Ops | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Invivyd Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Invivyd is extremely important. It helps to project a fair market value of Invivyd Stock properly, considering its historical fundamentals such as Net Income. Since Invivyd's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Invivyd's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Invivyd's interrelated accounts and indicators.
Click cells to compare fundamentals
Will Biotechnology sector continue expanding? Could Invivyd diversify its offerings? Factors like these will boost the valuation of Invivyd. Market participants price Invivyd higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Invivyd data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (0.45) | Revenue Per Share | Quarterly Revenue Growth 0.412 | Return On Assets | Return On Equity |
Understanding Invivyd requires distinguishing between market price and book value, where the latter reflects Invivyd's accounting equity. The concept of intrinsic value - what Invivyd's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Invivyd's price substantially above or below its fundamental value.
Please note, there is a significant difference between Invivyd's value and its price as these two are different measures arrived at by different means. Investors typically determine if Invivyd is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Invivyd's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Invivyd 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Invivyd's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Invivyd.
| 11/17/2025 |
| 02/15/2026 |
If you would invest 0.00 in Invivyd on November 17, 2025 and sell it all today you would earn a total of 0.00 from holding Invivyd or generate 0.0% return on investment in Invivyd over 90 days. Invivyd is related to or competes with OmniAb, C4 Therapeutics, Protara Therapeutics, Insight Molecular, Sangamo Therapeutics, Codexis, and NeOnc Technologies. Invivyd, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization ... More
Invivyd Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Invivyd's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Invivyd upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 5.55 | |||
| Information Ratio | 0.0185 | |||
| Maximum Drawdown | 46.37 | |||
| Value At Risk | (7.07) | |||
| Potential Upside | 11.11 |
Invivyd Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Invivyd's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Invivyd's standard deviation. In reality, there are many statistical measures that can use Invivyd historical prices to predict the future Invivyd's volatility.| Risk Adjusted Performance | 0.0313 | |||
| Jensen Alpha | 0.2244 | |||
| Total Risk Alpha | (0.36) | |||
| Sortino Ratio | 0.0251 | |||
| Treynor Ratio | (0.47) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Invivyd's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Invivyd February 15, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0313 | |||
| Market Risk Adjusted Performance | (0.46) | |||
| Mean Deviation | 4.94 | |||
| Semi Deviation | 5.21 | |||
| Downside Deviation | 5.55 | |||
| Coefficient Of Variation | 3605.61 | |||
| Standard Deviation | 7.53 | |||
| Variance | 56.76 | |||
| Information Ratio | 0.0185 | |||
| Jensen Alpha | 0.2244 | |||
| Total Risk Alpha | (0.36) | |||
| Sortino Ratio | 0.0251 | |||
| Treynor Ratio | (0.47) | |||
| Maximum Drawdown | 46.37 | |||
| Value At Risk | (7.07) | |||
| Potential Upside | 11.11 | |||
| Downside Variance | 30.79 | |||
| Semi Variance | 27.15 | |||
| Expected Short fall | (5.83) | |||
| Skewness | 2.03 | |||
| Kurtosis | 6.35 |
Invivyd Backtested Returns
Invivyd holds Efficiency (Sharpe) Ratio of -0.14, which attests that the entity had a -0.14 % return per unit of risk over the last 3 months. Invivyd exposes twenty-eight different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Invivyd's Risk Adjusted Performance of 0.0313, downside deviation of 5.55, and Market Risk Adjusted Performance of (0.46) to validate the risk estimate we provide. The company retains a Market Volatility (i.e., Beta) of -0.42, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Invivyd are expected to decrease at a much lower rate. During the bear market, Invivyd is likely to outperform the market. At this point, Invivyd has a negative expected return of -0.8%. Please make sure to check out Invivyd's potential upside, as well as the relationship between the kurtosis and day typical price , to decide if Invivyd performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.28 |
Weak reverse predictability
Invivyd has weak reverse predictability. Overlapping area represents the amount of predictability between Invivyd time series from 17th of November 2025 to 1st of January 2026 and 1st of January 2026 to 15th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Invivyd price movement. The serial correlation of -0.28 indicates that nearly 28.0% of current Invivyd price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.28 | |
| Spearman Rank Test | -0.02 | |
| Residual Average | 0.0 | |
| Price Variance | 0.13 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Invivyd Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Invivyd reported net income of (169.93 Million). This is 149.79% lower than that of the Biotechnology sector and significantly lower than that of the Health Care industry. The net income for all United States stocks is 129.76% higher than that of the company.
Invivyd Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Invivyd's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Invivyd could also be used in its relative valuation, which is a method of valuing Invivyd by comparing valuation metrics of similar companies.Invivyd is currently under evaluation in net income category among its peers.
Invivyd Current Valuation Drivers
We derive many important indicators used in calculating different scores of Invivyd from analyzing Invivyd's financial statements. These drivers represent accounts that assess Invivyd's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Invivyd's important valuation drivers and their relationship over time.
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 (projected) | ||
| Market Cap | 804.3M | 162.4M | 431.5M | 52.5M | 60.4M | 57.4M | |
| Enterprise Value | 262.1M | 74.1M | 233.1M | (15.5M) | (17.8M) | (16.9M) |
Invivyd Institutional Holders
Institutional Holdings refers to the ownership stake in Invivyd that is held by large financial organizations, pension funds or endowments. Institutions may hold large blocks of Invivyd's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Invivyd's value.| Shares | Geode Capital Management, Llc | 2025-06-30 | 637 K | Deutsche Bank Ag | 2025-06-30 | 585.4 K | Morgan Stanley - Brokerage Accounts | 2025-06-30 | 513.4 K | Gsa Capital Partners Llp | 2025-06-30 | 435.3 K | Aqr Capital Management Llc | 2025-06-30 | 423.5 K | Tang Capital Management Llc | 2025-06-30 | 400 K | Goldman Sachs Group Inc | 2025-06-30 | 387.9 K | Cubist Systematic Strategies, Llc | 2025-06-30 | 326.8 K | State Street Corp | 2025-06-30 | 272.9 K | Mithril Ii Gp Lp | 2025-06-30 | 11.2 M | Maverick Capital Ltd | 2025-06-30 | 10.2 M |
Invivyd Fundamentals
| Return On Equity | -0.68 | ||||
| Return On Asset | -0.26 | ||||
| Profit Margin | (1.20) % | ||||
| Operating Margin | (0.84) % | ||||
| Current Valuation | 359.02 M | ||||
| Shares Outstanding | 281.99 M | ||||
| Shares Owned By Insiders | 11.28 % | ||||
| Shares Owned By Institutions | 82.31 % | ||||
| Number Of Shares Shorted | 22.33 M | ||||
| Price To Book | 4.74 X | ||||
| Price To Sales | 8.79 X | ||||
| Revenue | 25.38 M | ||||
| Gross Profit | 46.71 M | ||||
| EBITDA | (173.76 M) | ||||
| Net Income | (169.93 M) | ||||
| Cash And Equivalents | 418.67 M | ||||
| Cash Per Share | 3.84 X | ||||
| Total Debt | 1.3 M | ||||
| Debt To Equity | 0 % | ||||
| Current Ratio | 9.14 X | ||||
| Book Value Per Share | 0.43 X | ||||
| Cash Flow From Operations | (170.49 M) | ||||
| Short Ratio | 6.81 X | ||||
| Earnings Per Share | (0.45) X | ||||
| Target Price | 10.0 | ||||
| Number Of Employees | 99 | ||||
| Beta | 0.6 | ||||
| Market Capitalization | 439.9 M | ||||
| Total Asset | 129.51 M | ||||
| Retained Earnings | (901.99 M) | ||||
| Working Capital | 38.7 M | ||||
| Net Asset | 129.51 M |
About Invivyd Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Invivyd's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Invivyd using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Invivyd based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Invivyd is a strong investment it is important to analyze Invivyd's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Invivyd's future performance. For an informed investment choice regarding Invivyd Stock, refer to the following important reports:Check out For information on how to trade Invivyd Stock refer to our How to Trade Invivyd Stock guide.You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Will Biotechnology sector continue expanding? Could Invivyd diversify its offerings? Factors like these will boost the valuation of Invivyd. Market participants price Invivyd higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Invivyd data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (0.45) | Revenue Per Share | Quarterly Revenue Growth 0.412 | Return On Assets | Return On Equity |
Understanding Invivyd requires distinguishing between market price and book value, where the latter reflects Invivyd's accounting equity. The concept of intrinsic value - what Invivyd's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Invivyd's price substantially above or below its fundamental value.
Please note, there is a significant difference between Invivyd's value and its price as these two are different measures arrived at by different means. Investors typically determine if Invivyd is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Invivyd's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.